Dr. Andrew Jinrui Warburton
Admissions Counselor - Icahn School of Medicine
Andrew is a medical student at the Icahn School of Medicine at Mount Sinai pursuing a career in Anesthesiology. He has a startup valued at $12 million which focuses on providing affordable vision care across the US, has >20 peer-reviewed publications, and is looking to continue to help others in their medical careers. Originally from the greater Pittsburgh area, Andrew went to public school all his life and attended the University of Pittsburgh, where he majored in computational chemistry with a focus in biology. He conducted research through the Department of Biomedical Informatics, where he published a paper in Scientific Reports on long non-coding RNA SNHG7 and its impact on breast cancer. He graduated in three years from Pitt and went straight to medical school at the Icahn School of Medicine at Mount Sinai. During his first year there, he joined multiple research labs focusing on large-data analysis and machine learning. He also co-founded Retina Technologies Inc., a company aimed to disrupt vision care by leveraging virtual reality, retinal imaging, and machine learning onto a portable platform to provide affordable, accessible, and accurate vision screening across the country.